Drug Trial Radar · NCT02674399
A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis
Last checked: Nov 19, 2026Latest source record: Aug 10, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
28
Actual
Start
Feb 16, 2016
Primary completion
Mar 12, 2018
Study completion Dec 28, 2018
Sponsor
- Lead sponsor
- Nature Cell Co. Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- KCRN Research, LLC
- First posted
- Feb 4, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 22 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a double-blind, randomized, controlled study with two arms to evaluate JointStem as a treatment for subjects with osteoarthritis. Following a 2-week screening period, approximately 30 subjects will be randomly assigned into one of the following two arms in a 2:1 ratio (2 JointStem : 1 positive control). After each subject completes 6-month visit (Visit 6) and the data management team confirms all data have no issue, the individual database will be locked and the blinding will be open for the statistical analysis.Only subjects who are assigned will be requested to visit the study center for 9-month and 12-month follow-up visits (Visits 7 and 8). To see long-term effects of JointStem, all subjects who complete Visit 6 will be requested to visit the study center at 24-month after the injection.
Conditions
- Osteoarthritis, Knee
Interventions
JointStemDrug
Synvisc-OneDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline on Western Ontario and McMaster Universities Arthritis Index (WOMAC) Score in JointStem GroupTime frame: Baseline and 6 months
- Change From Baseline on Visual Analog Scale (VAS) in JointStem GroupTime frame: Baseline and 6 months
- MRI Improvement Evaluation in JointStem GroupTime frame: 6 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Orthopedic Pain Specialists
Santa Monica, California
Site not named
Walnut Creek, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.